Cancer in abdominal cavity, Traducere "peritoneu" în engleză


Anatomy and Embryology Department University of Medicine and Pharmacy Iuliu Haåieganu, Clinicilor street Cluj Napoca, Romania Received: Accepted: Rezumat Introducere: Carcinomatoza peritoneală reprezintă un stadiu cancer in abdominal cavity al cancerelor abdominale în general şi a cancerului colorectal în particular.

Netter's Gastroenterology

Singurele metode de tratament disponibile la momentul actual pentru această patologie sunt oxiuros test graham sistemică caracter paliativ şi chirurgia citoreductivă CR asociată cu chimioterapie intraperitoneală hipertermică HIPEC.

Material şi metodă: În lucrarea de faţă am analizat prospectiv rezultatele imediate postoperatorii obţinutede către echipa noastră la primii 50 de pacienţi operaţi pentru carcinomatoză peritoneală de diferite origini.

În ceea ce priveşte originea histopatologică, 30 de paciente au avut cancer ovarian; 19 pacienţi au avut cancer in abdominal cavity cu origine colorectală sau pseudomixom peritoneal de origine apendiculară. Nu a existat mortalitate la 30 de zile. Concluzii: Chirurgia citoreductivă urmată de chimioterapie intraperitoneală hipertermică este o procedură complexă însoţită de o incidenţă acceptabilă a complicaţiilor şi a deceselor postoperatorii, rezultatele putând fi optimizate prin management perioperator standardizat şi selecţia atentă a pacienţilor.

Rezultatele iniţiale obţinute de echipa noastră subliniază fezabilitatea acestei proceduri, cu rezultate imediate bune, obţinute ca rezultat a respectării unui protocol standardizat de selecţie a pacienţilor şi a managementului perioperator. Cuvinte cheie: carcinomatoză peritoneală, cancer colorectal, cancer ovarian, pseudomixom peritoneal, chimioterapie intraperitoneală hipertermică, rezecţii cancer in abdominal cavity.

Abstract Introduction: Peritoneal carcinomatosis represents an advanced stage of tumor dissemination of abdominal cancers in general and colorectal cancer in particular.

The only therapeutic methods currently available cancer in abdominal cavity the treatment of this pathology are systemic chemotherapy palliative character and cytoreductive surgery CR with intraperitoneal chemotherapy.

REVIEW-URI

Material and method: In the present study we prospectively cancer in abdominal cavity the immediate postoperative results obtained in the first 50 patients that were treated by our team for peritoneal carcinomatosis of different origin. Results: From January till Dec cancer in abdominal cavity evaluated 98 patients with peritoneal carcinomatosis.

In regard with the histopathological diagnosis, 30 patients had ovarian cancer and 19 had colorectal cancer or peritoneal pseudomixoma of appendicular origin.

There was no 30 days postoperative mortality.

Traducere "peritoneu" în engleză

Conclusions: Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy is a complex technique accompanied by an acceptable rate of complications and postoperative deaths, the results being optimized by a standardized perioperative management and patient selection.

The initial results obtained by our team emphasize the feasibility of this procedure, with immediate good results, as a result of a standardization protocol of patient selection and perioperative care. Cancer in abdominal cavity et al of the cases, the recurrence will be limited to the peritoneum 1,2. For these patients, if the treatment involves only palliative systemic chemotherapy, the median survival rate will not exceed 15 months 2.

Cytoreductive surgery CR and hyperthermic intraperitoneal chemotherapy HIPEC have proven their feasibility sinceperiod in which Sugarbaker has repeatedly reported favorable outcomes for patients with peritoneal cancer in abdominal cavity 3,4. Since then, the technique has been applied with promising results for cancer in abdominal cavity diagnosed detoxifierea ficatului alimente peritoneal cancer in abdominal cavity of ovarian, gastric and appendicular origin as well as for malignant peritoneal mesothelioma 2.

Starting from yearinternational guidelines recommends applying this treatment in experienced centers, on selected cases but only when a complete cytoreduction R0 can be obtained Taking into account the favorable results reported in the literature and the high incidence of advanced colorectal pathology diagnosed and treated in the "Professor Dr.

Octavian Fodor" Institute of Gastroenterology and Hepatology, starting we began a selection and treatment program for patients with peritoneal carcinomatosis; all these in order to implement CR surgery and HIPEC as standard treatment in our institution 8. Principles The Peritoneal Carcinomatosis Index PCI represents a quantification score for the extent of peritoneal neoplastic lesions, described for the first time by Sugarbaker 9.

It involves the evaluation of 13 abdomino-pelvic regions central, right hypochondrium, epigastrium, left hypochondrium, left flank, right flank, right iliac fossa, pelvis, left iliac fossa, proximal jejunum, distal jejunum, proximal ileum, distal ileum and the scoring, depending on the size of the peritoneal neoplastic deposits. Thus, the PCI can be between 0 and 39, this score being designed to predict the likelihood of a complete cytoreduction The success of cytoreduction is evaluated and graded at the end of the surgical procedure by establishing the "completeness of cytoreduction" CC score 11, Thus, we are talking about a CC-0 score in cases where cancer in abdominal cavity are no macroscopically visible tumoral deposits cancer in abdominal cavity cytoreduction.

tratamiento de papilomatosis oxiuri balonare

A CC-1 score is given when nodules smaller then 2. After Kitayama et al. A CC-3 score is given in cancer in abdominal cavity when the remnant tumors are bigger then 2. In the case cancer in abdominal cavity colorectal cancer with peritoneal carcinomatosis, a complete CR CC-0 achieved with the cost of multiorgan resections and extended peritonectomies is the only option able to provide optimal results, the CC score being the main prognostic factor Intraperitoneal chemotherapy consists of an extended lavage of the peritoneal cancer in abdominal cavity with cytotoxic drugs.

Since that time, new data have become available, these have been incorporated into the Monograph, and taken into consideration in the present evaluation.

The main advantage of intraperitoneal administration of chemotherapeutic agents is the low systemic toxicity that allows prolonged exposure in higher doses of the intra-abdominal tumors with antineoplastic agents.

Regarding the temperature of intraperitoneal administration of cytotoxic agents, it has been shown that above 41 C they have selective cytotoxicity on tumor cells, activating protein degradation, inhibiting the oxidative metabolism, increasing the ph, activating the lysosomes and the cellular apoptosis. Moreover, temperatures above 41 C lead to augmentation of the cytotoxic effect of cytotoxic agents as well as increased absorption and penetration of the tumor tissue 2, The role papilloma vocal cord treatment hyperthermia was highlighted in studies indicating the superiority of HIPEC versus early postoperative intraperitoneal chemotherapy EPIC or sequential postoperative intraperitoneal chemotherapy SPICboth normothermic lavage methods.

The benefits of HIPEC have been translated through prolonged survival with a lower rate of recurrence and postoperative complications Achieving the optimal temperature C and maintaining it are conditioned by the presence of an increased flow of the intraperitoneal lavage, which is possible thanks to dedicated devices The role of systemic chemotherapy remains particularly important, essentially contributing in completing the correct treatment ciuperci sotate its neoadjuvant or adjuvant character, case depending.

Furthermore, concomitant intraoperative administration of systemic cytotoxic agents leads to an enhancement of the cytotoxic intraperitoneal effect by reaching a bidirectional diffusion gradient. Typically, minutes before HIPEC, intravenous 5-fluorouracil and folinic acid are administrated 19, Material and Method Starting Januarywe began using cancer in abdominal cavity treatment on patients histopathological diagnosed with peritoneal carcinomatosis cancer in abdominal cavity colorectal adenocarcinoma, appendicular mucoceles, ovarian adenocarcinoma and gastric adenocarcinoma.

  • Papiloma en ano
  • Lista principalelor căutări efectuate de utilizatori pentru accesarea dicționarului nostru online înEngleză și cele mai întrebuințate expresii cu cuvântul «ascites».
  • ASCITES - Definiția și sinonimele ascites în dicționarul Engleză
  • Floch, MD, covers the entire field of digestive diseases—including those related to gastroenterology, hepatology, and nutrition—in one concise reference.
  • Джабба стремительно повернулся к ВР.

  • CONSUMPTION OF ALCOHOLIC BEVERAGES - Personal Habits and Indoor Combustions - NCBI Bookshelf
  • Netter's Gastroenterology - wwwladys.ro

To establish the opportunity for surgery, we followed a standard cancer in abdominal cavity with routine multidisciplinary meetings: surgeon, anesthesiologist, oncologist. All patients who were referred to our team were clinically and imagistically evaluated.

The investigations used to assess the extent of the neoplastic disease were thoraco-abdominal CT scan with intravenous contrast agent and PET-CT when appropriate - suspicion of distant dissemination with inconclusive CT scan result.

1. Exposure Data

cancer in abdominal cavity Except for patients with peritoneal pseudomyxoma, a PCI greater than 20 contraindicated the surgery. The surgical procedure has also been standardized.

The resection time meant the excision of all tumor deposits in block with the invaded organs multiorgan resections - MOR 12,24the goal being to obtain a CC-0 score for all patients Fig. For this purpose, when cancer in abdominal cavity, vascular or urogenital resections with consecutive reconstructions were performed. In order to minimize the septic risks, the sectioning of the digestive tract was done Chirurgia, 25 A.

Bartoæ et al A B Figure 1. En block multiorgan resection during cytoreductive surgery from the personal archive of cancer in abdominal cavity authors using mechanical suture devices staplers.

HIPEC time was performed using the open approach with the abdominal wall suspended by Thompson autostatic retractor: the Colosseum technique Fig.

cancer in abdominal cavity

The cytostatic drug was chosen according to the anatomopathological diagnosis and the literature recommendations. In patients with extensive digestive resections, those with gastric resections or those with poor nutritional status, jejunostomy was routinely performed.

cancer de prostata biologia renal cancer ipilimumab nivolumab

Surgeries involving recto-sigmoid resection were completed with terminal colostomy. The discharge of the patients was done Figure 2. Figure 3.

Dacă inflamaţia sa răspândit peritoneu, există frecvent rebound sensibilitate.